Back to Results
First PageMeta Content
Chemistry / Organofluorides / Orphan drugs / Harvard Medical School / Pyridines / Renal cell carcinoma / Kidney tumour / Sorafenib / Sunitinib / Medicine / Kidney cancer / Oncology


Newsletter of the DF/HCC KCP Kidney Cancer Program
Add to Reading List

Document Date: 2011-08-31 17:02:37


Open Document

File Size: 343,68 KB

Share Result on Facebook

City

Houston / Boston / Cambridge / MS424 Boston / /

Company

Novartis / Genentech Inc. / Patient Advocacy Group / Dana / Wilex Pharmaceuticals / Onyx Pharmaceuticals / /

Country

United States / Argentina / /

/

EntertainmentAwardEvent

Joint Career Developmental Award / Director’s Choice Award / /

Event

FDA Phase / Product Issues / Person Communication and Meetings / Employment Change / /

Facility

Institute of Medicine / MD Anderson Cancer Center / GENERAL HOSPITAL Children’s Hospital / Beth Israel Deaconess Medical Center / DanaFarber Cancer Institute / News The Howard Hughes Medical Institute / Massachusetts General Hospital / Women’s Hospital / Current Clinical Trials BRIGHAM AND WOMEN’S HOSPITAL / Laboratory Correlates / /

/

IndustryTerm

energy generating mechanism / cancer therapy / imaging / energy / ultrasound imaging / treatment of kidney cancer / Therapy of Cancer / database protocol / Tissue banking / conventional imaging / /

MedicalCondition

Subjects With Advanced Renal Cell Carcinoma / response rate median tumor / Wilms Tumor / months Median OS renal cell carcinoma / Hereditary Leiomyomatosis / metastatic disease / Renal Cancer / Characterize Renal Cell Carcinoma Andrew A. Wagner / Resected Renal Cell Carcinoma / tumor / clear cell renal carcinoma / cancer / tumors / Metatastic Renal Cell Carcinoma / tumor VHL / Kidney Cancer SPORE / renal cancers / Advanced Renal Cell Carcinoma / primary tumor / Advanced Disease / DF / particularly invasive kidney cancers / benign leiomyomas / renal cell carcinoma / FH deficiency / Small Renal Tumors / renal clear cell carcinoma / Metastatic Renal Cell Carcinoma / CAIX positive clear cell renal cell carcinoma / renal clear cell carcinomas / Renal Cell Cancer / kidney cancer / translational kidney cancer / /

MedicalTreatment

Vaccination / Adoptive Immunotherapy / surgery / cancer therapy / Adjuvant Therapy / /

Organization

Harvard Cancer Center / Harvard School of Public Health From / Society for Biological Therapy of Cancer / Kidney Cancer Association / DanaFarber Cancer Institute / VHL Family Alliance / DF / Department of Radiology / Harvard / Institute of Medicine / Beth Israel Deaconess Medical Center / Women’s Hospital / Massachusetts General Hospital / Harvard School of Public Health / Howard Hughes Medical Institute / /

Person

Vikas Sukhatme / Aline Nandelstadt / James W. Mier / Donald W. Kufe / Aron Libermann / Neil M. Rofsky / Annick Van Debeele / Sandra L. Dabora / David Frank / Miguel Rivera / Peter Raff Mueller / Luiz F. Zerbini / Sabina Signoretti / William G. Kaelin / Robert W. Ross / David Avigan / David McDermott / Steve Skates / Meredith Regan / Toni K. Choueiri / Michael B. Atkins / Meredith M. Regan / David C. Alsop / Nahum Goldberg / Daniel Haber / Joseph V. Bonventre / Michael Atkins / Beth Israel / Aria F. Olumi / Pankaj Seth / Chris Wood / Michelle S. Hirsch / Doug Dahl / Allison Friedman / Patrick Yung Chih Wen / Othon Iliopoulos / Bob Rebello / Don Kufe / Alan Rigby / Michael Zimmer / Talia Schwartzberg / David F. McDermott / William Kaelin / Daniel Cho / James Mier / Daniel A. Haber / Ivan Pedrosa / Towia Libermann / Pier Paolo Pandolfi / David E. Avigan / Chin-Lee Wu / Deborah Burstein / Progress By Vikas Sukhatme / David Panka / Seth Leo Alper / Steven J. Skates / S. Nahum Goldberg / Eunyoung Cho / Wayne A. Marasco / Dan Haber / Symposium Held By David McDermott / Daniel C. Cho / Kevin R. Loughlin / Launch By Annick Van Den Abbeele / Andrew A. Wagner / Aline D. Nandelstadt / /

/

Position

Pathology Core Director / Chief Academic Officer / Director of the Tissue Acquistion Pathology and Clinical Data Core / young investigator / advocate / Director By Michael / Administrator / Program Director / Kidney Cancer Program leader / Program Administrator / Ph.D HHMI investigator / Director / nurse / Co-Leader / HHMI investigator / /

Product

HMS / Perifosine Following Tyrosine / ABT-869 / Adjuvant Sunitinib / cG250 / VHL protein / /

ProvinceOrState

Massachusetts / /

PublishedMedium

Magnetic Resonance Imaging / /

RadioStation

Core / /

Technology

Magnetic Resonance Imaging / treating cancer / genotype / ultrasound / database protocol / MRI / /

URL

www.dfhcc.harvard.edu/renalcancer / http /

SocialTag